| scholarly article | Q13442814 |
| P2093 | author name string | Williams JI | |
| Kleinman I | |||
| Schachter D | |||
| P2860 | cites work | Quality of care in family practice: does residency training make a difference? | Q34103480 |
| Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. | Q34246646 | ||
| Evidence for the effectiveness of CME. A review of 50 randomized controlled trials | Q35687835 | ||
| Five-year results of the peer assessment program of the College of Physicians and Surgeons of Ontario | Q37975990 | ||
| CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs | Q39388607 | ||
| Disclosure of tardive dyskinesia: effect of written policy on risk disclosure | Q41089751 | ||
| Informed consent and tardive dyskinesia. Long-term follow-up | Q41131239 | ||
| Study of relation of continuing medical education to quality of family physicians' care | Q41266396 | ||
| Emerging roles for novel antipsychotic medications in the treatment of schizophrenia | Q41743497 | ||
| Tardive dyskinesia and informed consent | Q46327667 | ||
| Legal aspects of neuroleptic-induced movement disorders. | Q51227997 | ||
| Psychiatrists' documentation of informed consent. | Q51988581 | ||
| Documenting informed consent for treatment with neuroleptics: an alternative to the consent form. | Q52008985 | ||
| Informed consent: the physicians' perspective | Q57194825 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | informed consent | Q764527 |
| P304 | page(s) | 1502-1508 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Canadian Family Physician | Q5029982 |
| P1476 | title | Informed consent for antipsychotic medication | |
| P478 | volume | 45 |
Search more.